Abstract
Correction to "Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment".
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have